Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1

International Journal of Cancer

Volumn 130, Issue 8, 2012, Pages 1787-1797

  Boyerinas, Benjamin ^a,b   Park, Sun Mi ^a,c   Murmann, Andrea E ^a   Gwin, Katja ^b   Montag, Anton G ^b   Zillhardt, Marion ^b   Hua, You Jia ^a   Lengyel, Ernst ^b   Peter, Marcus E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c NONE   (United States)

Author keywords

IMP 1; let 7; Lin28; MDR1; Taxol

Indexed keywords

CARBOPLATIN; IMP 1 PROTEIN; LET 7; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; RNA BINDING PROTEIN; TAXANE DERIVATIVE; UNCLASSIFIED DRUG; VINBLASTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER RESISTANCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; UPREGULATION;

EID: 84857503465     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26190     Document Type: Article

References (42)

1. Yap TA, Carden CP, Kaye SB,. Beyond chemotherapy: targeted therapies in ovarian cancer. Nat Rev Cancer 2009; 9: 167-81.
2. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Gottesman MM,. P-glycoprotein: from genomics to mechanism. Oncogene 2003; 22: 7468-85.
3. Zhou SF,. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 2008; 38: 802-32.
4. Bartel DP,. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-33.
5. Boyerinas B, Park SM, Hau A, Murmann AE, Peter ME,. The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer 2010; 17: F19-36.
6. Cochrane DR, Spoelstra NS, Howe EN, Nordeen SK, Richer JK,. MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. Mol Cancer Ther 2009; 8: 1055-66.
7. Mishra PJ, Humeniuk R, Longo-Sorbello GS, Banerjee D, Bertino JR,. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc Natl Acad Sci USA 2007; 104: 13513-8.
8. Zhu H, Wu H, Liu X, Evans BR, Medina DJ, Liu CG, Yang JM,. Role of microRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 2008; 76: 582-8.
9. Pan YZ, Morris ME, Yu AM,. MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells. Mol Pharmacol 2009; 75: 1374-9.
10. To KK, Zhan Z, Litman T, Bates SE,. Regulation of ABCG2 expression at the 3†untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line. Mol Cell Biol 2008; 28: 5147-61.
11. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, Song E,. Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007; 131: 1109-23.
12. Chen GQ, Zhao ZW, Zhou HY, Liu YJ, Yang HJ,. Systematic analysis of microRNA involved in resistance of the MCF-7 human breast cancer cell to doxorubicin. Med Oncol 2009; 27: 406-15.
13. Blower PE, Chung JH, Verducci JS, Lin S, Park JK, Dai Z, Liu CG, Schmittgen TD, Reinhold WC, Croce CM, Weinstein JN, Sadee W,. MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther 2008; 7: 1-9.
14. Weidhaas JB, Babar I, Nallur SM, Trang P, Roush S, Boehm M, Gillespie E, Slack FJ,. MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res 2007; 67: 11111-6.
15. Yang N, Kaur S, Volinia S, Greshock J, Lassus H, Hasegawa K, Liang S, Leminen A, Deng S, Smith L, Johnstone CN, Chen XM, et al. MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res 2008; 68: 10307-14.
16. Boyerinas B, Park SM, Shomron N, Hedegaard MM, Vinther J, Andersen JS, Feig C, Xu J, Burge CB, Peter ME,. Identification of let-7-regulated oncofetal genes. Cancer Res 2008; 68: 2587-91.
17. Atlas R, Behar L, Elliott E, Ginzburg I,. The insulin-like growth factor mRNA binding-protein IMP-1 and the Ras-regulatory protein G3BP associate with tau mRNA and HuD protein in differentiated P19 neuronal cells. J Neurochem 2004; 89: 613-26.
18. Bernstein PL, Herrick DJ, Prokipcak RD, Ross J,. Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant. Genes Dev 1992; 6: 642-54.
19. Doyle GA, Betz NA, Leeds PF, Fleisig AJ, Prokipcak RD, Ross J,. The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins. Nucleic Acids Res 1998; 26: 5036-44.
20. Leeds P, Kren BT, Boylan JM, Betz NA, Steer CJ, Gruppuso PA, Ross J,. Developmental regulation of CRD-BP, an RNA-binding protein that stabilizes c-myc mRNA in vitro. Oncogene 1997; 14: 1279-86.
21. Nielsen FC, Nielsen J, Christiansen J,. A family of IGF-II mRNA binding proteins (IMP) involved in RNA trafficking. Scand J Clin Lab Invest Suppl 2001; 234: 93-9.
22. Noubissi FK, Elcheva I, Bhatia N, Shakoori A, Ougolkov A, Liu J, Minamoto T, Ross J, Fuchs SY, Spiegelman VS,. CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling. Nature 2006; 441: 898-901.
23. Prokipcak RD, Herrick DJ, Ross J,. Purification and properties of a protein that binds to the C-terminal coding region of human c-myc mRNA. J Biol Chem 1994; 269: 9261-9.
24. Rackham O, Brown CM,. Visualization of RNA-protein interactions in living cells: FMRP and IMP1 interact on mRNAs. EMBO J 2004; 23: 3346-55.
25. Runge S, Nielsen FC, Nielsen J, Lykke-Andersen J, Wewer UM, Christiansen J,. H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein. J Biol Chem 2000; 275: 29562-9.
26. Sparanese D, Lee CH,. CRD-BP shields c-myc and MDR-1 RNA from endonucleolytic attack by a mammalian endoribonuclease. Nucleic Acids Res 2007; 35: 1209-21.
27. Vikesaa J, Hansen TV, Jonson L, Borup R, Wewer UM, Christiansen J, Nielsen FC,. RNA-binding IMPs promote cell adhesion and invadopodia formation. EMBO J 2006; 25: 1456-68.
28. Sawada K, Radjabi AR, Shinomiya N, Kistner E, Kenny HA, Salgia R, Yamada SD, Vande Woude GF, Tretiakova MS, Lengyel E,. C-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion. Cancer Res 2007; 67: 1670-80.
29. Terplan M, Temkin S, Tergas A, Lengyel E,. Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancer. Gynecol Oncol 2008; 111: 173-8.
30. Kobel M, Weidensdorfer D, Reinke C, Lederer M, Schmitt WD, Zeng K, Thomssen C, Hauptmann S, Huttelmaier S,. Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma. Oncogene 2007; 26: 7584-89.
31. Cook RD,. Detection of influential observations in linear regression. Technometrics 1977; 19: 15-18.
32. Jorgensen S, Baker A, Moller S, Nielsen BS,. Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes. Methods 2010; 52: 375-81.
33. Newman MA, Thomson JM, Hammond SM,. Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. RNA 2008; 14: 1539-49.
34. Viswanathan SR, Daley GQ, Gregory RI,. Selective blockade of microRNA processing by Lin28. Science 2008; 320: 97-100.
35. Legrand O, Simonin G, Perrot JY, Zittoun R, Marie JP,. Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients. Blood 1998; 91: 4480-8.
36. Lemaire S, Van Bambeke F, Mingeot-Leclercq MP, Tulkens PM,. Modulation of the cellular accumulation and intracellular activity of daptomycin towards phagocytized Staphylococcus aureus by the P-glycoprotein (MDR1) efflux transporter in human THP-1 macrophages and madin-darby canine kidney cells. Antimicrob Agents Chemother 2007; 51: 2748-57.
37. Park SW, Lomri N, Simeoni LA, Fruehauf JP, Mechetner E,. Analysis of P-glycoprotein-mediated membrane transport in human peripheral blood lymphocytes using the UIC2 shift assay. Cytometry A 2003; 53: 67-78.
38. Babakhanian K, Bendayan M, Bendayan R,. Localization of P-glycoprotein at the nuclear envelope of rat brain cells. Biochem Biophys Res Commun 2007; 361: 301-6.
39. Nielsen J, Adolph SK, Rajpert-De Meyts E, Lykke-Andersen J, Koch G, Christiansen J, Nielsen FC,. Nuclear transit of human zipcode-binding protein IMP1. Biochem J 2003; 376 (Pt 2): 383-91.
40. Goda K, Bacso Z, Szabo G,. Multidrug resistance through the spectacle of P-glycoprotein. Curr Cancer Drug Targets 2009; 9: 281-97.
41. Shimizu S, Takehara T, Hikita H, Kodama T, Miyagi T, Hosui A, Tatsumi T, Ishida H, Noda T, Nagano H, Doki Y, Mori M, et al. The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. J Hepatol 2010; 52: 698-704.
42. Turk D, Szakacs G,. Relevance of multidrug resistance in the age of targeted therapy. Curr Opin Drug Discov Devel 2009; 12: 246-52.